PDF Publication Title:
Text from PDF Page: 016
Dovepress Photodynamic therapy in dermatology 39. Wiegell SR, Fabricius S, Stender IM et al. A randomized, multicentre study of directed daylight exposure times of 1(1/2) vs 2(1/2) h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol. 2011;164(5):1083–1090. 40. Wiegell SR, Fabricius S, Gniadecka M, et al. Daylight-mediated photo- dynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol. 2012;166(6): 1327–1332. 41. Wiegell SR, Wulf HC, Szeimies RM, et al. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol. 2012;26(6):673–679. 42. Wiegell SR, Fabricius S, Heydenreich J, et al. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations. Br J Dermatol. 2013;168(1):186–191. 43. Wiegell SR, Skødt V, Wulf HC. Daylight-mediated photodynamic therapy of basal cell carcinomas – an explorative study. J Eur Acad Dermatol Venereol. January 7, 2013. [Epub ahead of print.] 44. Dirschka T, Radny P, Dominicus R, et al. Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled Phase III trials of photodynamic therapy with BF-200 ALA and methyl amino- laevulinate for the treatment of actinic keratosis. Br J Dermatol. 2013;168(4):825–836. 45. Braathen LR, Paredes BE, Saksela O, et al. Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses. J Eur Acad Dermatol Venereol. 2009;23(5):550–555. 46. Moseley H, Brancaleon L, Lesar AE, Ferguson J, Ibbotson SH. Does surface preparation alter ALA uptake in superficial non-melanoma skin cancer in vivo? Photodermatol Photoimmunol Photomed. 2008;24(2):72–75. 47. Torezan L, Chaves Y, Niwa A, Sanches JA Jr, Festa-Neto C, Szeimies RM. A pilot split-face study comparing conventional methyl aminolevulinate- photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin. Dermatol Surg. 2013;39(8):1197–1201. 48. Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, Hædersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol. 2012;166(6):1262–1269. 49. Hong JS, Jung JY, Yoon JY, Suh DH. Acne treatment by methyl aminolevulinate photodynamic therapy with red light vs intense pulsed light. Int J Dermatol. 2013;52(5):614–619. 50. Clark C, Bryden A, Dawe R, Moseley H, Ferguson J, Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed. 2003;19(3):134–141. 51. Gholam P, Kroehl V, Enk AH. Dermatology life quality index and side effects after topical photodynamic therapy of actinic keratosis. Dermatology. 2013;226(3):253–259. 52. Orenstein A, Kostenich G, Tsur H, Kogan L, Malik Z. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. Cancer Lett. 1995;93(2):227–232. 53. Kasche A, Luderschmidt S, Ring J, Hein R. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared with aminolevulinic acid. J Drugs Dermatol. 2006;5(4):353–356. 54. Wiegell SR, Stender IM, Na R, Wulf HC. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevu- linic acid methylester on tape-stripped normal skin. Arch Dermatol. 2003;139(9):1173–1177. 55. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–968. 56. Lee Y, Baron ED. Photodynamic therapy: current evidence and applica- tions in dermatology. Semin Cutan Med Surg. 2011;30(4):199–209. 57. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415. Clinical, Cosmetic and Investigational Dermatology 2014:7 58. Gupta AK, Paquet M. Network meta-analysis of the outcome ‘participant complete clearance’ in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review. Br J Dermatol. 2013;169(2):250–259. 59. Hauschild A, Popp G, Stockfleth E, et al. Effective photodynamic ther- apy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch. Exp Dermatol. 2009;18(2):116–121. 60. Hauschild A, Stockfleth E, Popp G, et al. Optimization of photody- namic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled Phase III studies. Br J Dermatol. 2009;160(5):1066–1074. 61. Serra-Guillén C, Nagore E, Hueso L, et al. A randomized pilot com- parative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J Am Acad Dermatol. 2012;66(4):e131–e137. 62. Truchuelo M, Fernández-Guarino M, Fleta B, Alcántara J, Jaén P. Effectiveness of photodynamic therapy in Bowen’s disease: an obser- vational and descriptive study in 51 lesions. J Eur Acad Dermatol Venereol. 2012;26(7):868–874. 63. Bath-Hextall FJ, Matin RN, Wilkinson D, Leonardi-Bee J. Interventions for cutaneous Bowen’s disease. Cochrane Database Syst Rev. 2013;6:CD007281. 64. Salim A, Leman JA, McColl JH, Chapman R, Morton CA. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br J Dermatol. 2003;148(3):539–543. 65. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol. 2006;142(6):729–735. 66. Perrett CM, McGregor JM, Warwick J, et al. Treatment of post- transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. Br J Dermatol. 2007;156(2):320–328. 67. de Haas ER, Sterenborg HJ, Neumann HA, Robinson DJ. Response of Bowen disease to ALA-PDT using a single and a 2-fold illumination scheme. Arch Dermatol. 2007;143(2):264–265. 68. Puizina-Ivić N, Zorc H, Vanjaka-Rogosić L, Mirić L, Persin A. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Antropol. 2008;32 Suppl 2:67–73. 69. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol. 2000;142(2):338–339. 70. Morton CA, McKenna KE, Rhodes LE; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. Guidelines for topical photodynamic therapy: update. Br J Dermatol. 2008;159(6):1245–1266. 71. Christensen E, Mørk C, Skogvoll E. High and sustained efficacy after two sessions of topical 5-aminolaevulinic acid photodynamic therapy for basal cell carcinoma: a prospective, clinical and histological 10-year follow-up study. Br J Dermatol. 2012;166(6):1342–1348. 72. Cosgarea R, Susan M, Crisan M, Senila S. Photodynamic therapy using topical 5-aminolaevulinic acid vs surgery for basal cell carcinoma. J Eur Acad Dermatol Venereol. 2013;27(8):980–984. 73. Roozeboom MH, Aardoom MA, Nelemans PJ, et al. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up. J Am Acad Dermatol. 2013;69(2):280–287. 74. Osiecka B, Jurczyszyn K, Ziółkowski P. The application of levulan- based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma. Med Sci Monit. 2012;18(2):PI5–PI9. 75. Basset-Seguin N, Ibbotson SH, Emtestam L, et al. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for super- ficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol. 2008;18(5):547–553. submit your manuscript | www.dovepress.com Dovepress 159PDF Image | applications of photodynamic therapy dermatology
PDF Search Title:
applications of photodynamic therapy dermatologyOriginal File Name Searched:
photodynamic-therapy-dermatology.pdfDIY PDF Search: Google It | Yahoo | Bing
Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info
Cruising Review Topics and Articles More Info
Software based on Filemaker for the travel industry More Info
The Burgenstock Resort: Reviews on CruisingReview website... More Info
Resort Reviews: World Class resorts... More Info
The Riffelalp Resort: Reviews on CruisingReview website... More Info
| CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com | RSS | AMP |